The Reporter Gene Assay Market size was estimated at USD 4.8 billion in 2019 and is projected to expand at a compound annual growth rate (CAGR) of 8.1% from 2020 to 2027 and reach 8.95 Billion.
Reporter genes are genes whose products can be readily assayed subsequent to transfection, and can be used as markers for screening successfully transfected cells, for studying regulation of gene expression, or serve as controls for standardizing transfection efficiencies. The ideal reporter gene should be absent from the cells used in the study or easily distinguishable from the native form of the gene, assayed conveniently, and have a broad linear detection range. It is also important that the presence of the reporter gene does not affect the normal physiology and general health of the transfected cells. Reporter genes have significant demand as they are increasingly being used in studying gene expression and across several research studies in the fields of biochemistry, molecular biology, and pharmaceuticals.
Factors contributing to the growth of this market include increasing funding for cell-based research, growing applications of gene expression, and rising preference for cell-based assays. Based on applications, the reporter gene assays market is segmented into gene regulation, protein interaction, Cell Signalling pathways, and promotor structural & functional analysis. The cell signalling pathway is projected to grow at the highest growth rate during the forecast period. On the basis of product, the market is broadly classified into assay kits and reagents. The assay kits segment is estimated to hold the largest share of the market in 2019 and is also projected to grow at the highest rate during the forecast period. The large share and high growth rate of the assay kits segment can be attributed to their repeated use in Gene Expression studies and signalling pathway analysis during gene transcription or translation levels.
Some key players of the reporter gene assay market are Thermo Fisher Scientific, Merck, PerkinElmer, Promega Corporation, Abcam, Biotium, Bio-Rad Laboratories, Danaher Corporation, Becton, Dickinson and Company, Geno Technology, InvivoGen, Genecopoeia, PromoCell, Lonza Group, Cell Signalling Technology, and General Electric.
Reporter genes are genes whose products can be readily assayed subsequent to transfection, and can be used as markers for screening successfully transfected cells, for studying regulation of gene expression, or serve as controls for standardizing transfection efficiencies. The ideal reporter gene should be absent from the cells used in the study or easily distinguishable from the native form of the gene, assayed conveniently, and have a broad linear detection range. It is also important that the presence of the reporter gene does not affect the normal physiology and general health of the transfected cells. Reporter genes have significant demand as they are increasingly being used in studying gene expression and across several research studies in the fields of biochemistry, molecular biology, and pharmaceuticals.
Factors contributing to the growth of this market include increasing funding for cell-based research, growing applications of gene expression, and rising preference for cell-based assays. Based on applications, the reporter gene assays market is segmented into gene regulation, protein interaction, Cell Signalling pathways, and promotor structural & functional analysis. The cell signalling pathway is projected to grow at the highest growth rate during the forecast period. On the basis of product, the market is broadly classified into assay kits and reagents. The assay kits segment is estimated to hold the largest share of the market in 2019 and is also projected to grow at the highest rate during the forecast period. The large share and high growth rate of the assay kits segment can be attributed to their repeated use in Gene Expression studies and signalling pathway analysis during gene transcription or translation levels.
Some key players of the reporter gene assay market are Thermo Fisher Scientific, Merck, PerkinElmer, Promega Corporation, Abcam, Biotium, Bio-Rad Laboratories, Danaher Corporation, Becton, Dickinson and Company, Geno Technology, InvivoGen, Genecopoeia, PromoCell, Lonza Group, Cell Signalling Technology, and General Electric.
- Aerospace and Defense
- Agriculture
- Automotive and Transportation
- Business and Finance
- Chemical and Materials
- Consumer Goods and Retails
- Electronics and Semiconductor
- Energy and Power
- Food and Beverages
- Machinery and Equipment
- Manufacturing and Construction
- Medical Devices
- Pharmaceuticals and Healthcare
- Service and Software
- Technology, Media and Telecommunications
- Travel and Tourism
